Wall Street Zen Upgrades Clover Health Investments (NASDAQ:CLOV) to "Strong-Buy"

Clover Health Investments logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Clover Health (CLOV) from “buy” to “strong-buy,” while broader analyst sentiment remains mixed: MarketBeat reports a consensus “hold” rating and an average price target of $5.10.
  • Clover beat quarterly expectations, reporting earnings of $0.01 per share versus a consensus estimate of a $0.01 loss, and revenue of $759.3 million versus estimates of $740.1 million.
  • Company insiders sold a combined 768,573 shares worth about $3.46 million in the last quarter; insiders currently own 23.51% of the stock.
  • MarketBeat previews the top five stocks to own by December 1st.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report issued on Saturday, Wall Street Zen reports.

Several other research analysts have also recently issued reports on CLOV. Needham & Company LLC reissued a "buy" rating on shares of Clover Health Investments in a research note on Thursday, November 5th. Weiss Ratings restated a "sell (d-)" rating on shares of Clover Health Investments in a report on Monday, September 21st. Deutsche Bank began coverage on Clover Health Investments in a research report on Thursday, September 10th. They set a "buy" rating and a $6.00 target price for the company. Zacks Research upgraded Clover Health Investments to a "hold" rating in a report on Monday, September 14th. Finally, UBS Group increased their price target on Clover Health Investments from $5.00 to $5.50 and gave the stock a "neutral" rating in a research report on Thursday, November 5th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $5.10.

Read Our Latest Stock Report on CLOV

Clover Health Investments Stock Performance

Shares of NASDAQ:CLOV opened at $3.71 on Friday. The firm has a fifty day moving average price of $4.59 and a 200 day moving average price of $3.70. Clover Health Investments has a fifty-two week low of $1.58 and a fifty-two week high of $5.59. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of 371.87 and a beta of 2.52.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.02. Clover Health Investments had a net margin of 0.45% and a return on equity of 4.66%. The company had revenue of $759.30 million for the quarter, compared to analysts' expectations of $740.07 million. As a group, research analysts predict that Clover Health Investments will post 0.06 earnings per share for the current year.

Insider Activity at Clover Health Investments

In related news, insider Karen Soares sold 19,275 shares of the stock in a transaction that occurred on Tuesday, October 20th. The shares were sold at an average price of $4.66, for a total value of $89,821.50. Following the transaction, the insider owned 1,573,423 shares in the company, valued at approximately $7,332,151.18. This represents a 1.21% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Joseph Frank Oldakowski sold 20,000 shares of the firm's stock in a transaction on Monday, September 14th. The stock was sold at an average price of $5.16, for a total transaction of $103,200.00. Following the transaction, the vice president directly owned 279,067 shares of the company's stock, valued at approximately $1,439,985.72. This trade represents a 6.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 768,573 shares of company stock worth $3,462,479 in the last quarter. 23.51% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Clover Health Investments

Hedge funds have recently modified their holdings of the company. Public Employees Retirement System of Ohio acquired a new position in Clover Health Investments in the 2nd quarter valued at $42,000. Nykredit A S purchased a new position in Clover Health Investments in the second quarter valued at about $45,000. Ballew Advisors Inc purchased a new position in Clover Health Investments in the 3rd quarter valued at approximately $44,000. Nisa Investment Advisors LLC increased its position in shares of Clover Health Investments by 223.4% in the third quarter. Nisa Investment Advisors LLC now owns 10,855 shares of the company's stock valued at $47,000 after buying an additional 7,498 shares in the last quarter. Finally, Allworth Financial LP boosted its position in shares of Clover Health Investments by 200.7% in the 3rd quarter. Allworth Financial LP now owns 12,281 shares of the company's stock worth $53,000 after buying an additional 8,197 shares in the last quarter. 19.77% of the stock is owned by hedge funds and other institutional investors.

Clover Health Investments Company Profile

(Get Free Report)

Clover Health Investments is a U.S. healthcare company focused on Medicare. Its insurance business offers Medicare Advantage plans to eligible beneficiaries in select markets, combining medical coverage with support intended to help members access care. The company also developed the Clover Assistant, a technology platform that organizes patient information and provides clinicians with insights to support care decisions. Clover has described the platform as a way to help primary care providers identify health needs and coordinate care for people with complex conditions.

Featured Articles

Analyst Recommendations for Clover Health Investments (NASDAQ:CLOV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clover Health Investments Right Now?

Before you consider Clover Health Investments, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.

While Clover Health Investments currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines